In vitro and in vivo neuromuscular effects of atracurium and rocuronium in rats treated with carbamazepine for seven days;Efeitos neuromusculares in vitro e in vivo do atracúrio e do rocurônio em ratos submetidos a tratamento de sete dias com carbamazepina

Revista Brasileira de Anestesiologia

Volumn 58, Issue 2, 2008, Pages 137-151

  De Barcelos, Caroline Coutinho ^a   Braga, Angélica De Fátima De Assunção ^a,b   Braga, Franklin Sarmento Da Silva ^a   Potério, Gloria Braga ^a   Fernandes, Samanta Cristina Antoniassi ^a   Franco, Yoko Oshima ^a   Simioni, Léa Rodrigues ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Cidade Universitaria   (Brazil)

Author keywords

Animals, rats; Anticonvulsants, carbamazepine; Neuromuscular blockers, non depolarizing: atracurium, rocuronium

Indexed keywords

ATRACURIUM; CARBAMAZEPINE; CYTOCHROME P450; OXIDOREDUCTASE; ROCURONIUM; URETHAN;

ANIMAL EXPERIMENT; ARTICLE; CHROMOSOME; CONTROLLED STUDY; DRUG EFFECT; IN VITRO STUDY; IN VIVO STUDY; MALE; NEUROMUSCULAR FUNCTION; NONHUMAN; RAT;

EID: 41249084676     PISSN: 00347094     EISSN: 1806907X     Source Type: Journal    
DOI: 10.1590/S0034-70942008000200006     Document Type: Article

References (50)

1. Martins RS, Martins ALC - Bloqueadores Neuromusculares, em: Manica J - Anestesiologia: Princípios e Técnicas. Porto Alegre, Artes Médicas, 1997;308-331.
2. Miranda FG, Marín JS, Aränó JA - Neurofisiologia de la Union Neuromuscular, em: Gómez JAA, Miranda FG, Bozzo RB - Relajantes Musculares em Anestesia y Terapia Intensiva. Madrid, Aran, 2000;61-70.
3. Cardoso LSM, Martins CR, Tardelli MA - Efeitos da lidocaína por via venosa sobre a farmacodinâmica do rocurônio. Rev Bras Anestesiol, 2005;55:371-380.
4. Loyola YCS, Braga AFA, Potério GMB et al. - Influência da lidocaína no bloqueio neuromuscular produzido pelo rocurônio. Estudo em preparação nervo frênico - diafragma de rato. Rev Bras Anestesiol, 2006;56:147-156.
5. Sousa SRS, Braga AFA, Potério GMB et al. - Influência da nifedipina no bloqueio neuromuscular produzido pelo atracúrio e pelo cisatracúrio. Estudo em preparações nervo frênico-diafragma de rato. Rev Bras Anestesiol, 2006;56:157-167.
6. Haywood PT, Divekar N, Karalliedde LD - Concurrent medication and the neuromuscular junction. Eur J Anaesthesiol, 1999;16:77-91.
7. Spacek A, Kress HG - Drug interactions with muscle relaxants. Acta Anaesthesiol Scand, 1998;42(Suppl 112):236-238.
8. Mei PA, Montenegro MA, Guerreiro MM et al. - Pharmacovigilance in epileptic patients using antiepileptic drugs. Arq Neuropsiquiatr, 2006;64:198-201.
9. a Ed. Rio de Janeiro, Churchill Livingstone Elsevier, 2003;627-639.
10. Perucca E - An introduction to antiepileptic drugs. Epilepsia, 2005;46:31-37.
11. Beydoun S, Alarcón F, Mangat S et al. - Long-term safety and tolerability of carbamazepine in painful diabetic neuropathy. Acta Neurol Scand, 2007;115:284-288.
12. Eisenberg E, River Y, Shifrin A et al. - Antiepileptic drugs in the treatment of neuropathic pain. Drugs, 2007;67:1265-1289.
13. Alloul K, Whalley DG, Shutway F et al. - Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients. Anesthesiology, 1996;84:330-339.
14. Nguyen A, Ramzan I - In vitro response of neuromuscular blockers after chronic carbamazepine treatment in rats. Pharmazie, 2000;55:957.
15. Richard A, Girard F, Girard DC et al. - Cisatracurium-induced neuromuscular blockade is affected by chronic phenytoin or carbamazepine treatment in neurosurgical patients. Anesth Analg, 2005;100:538-544.
16. Tempelhoff R, Modica PA, Jellish WS et al. - Resistance to atracurium-induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants. Anesth Analg, 1990;71:665-669.
17. Spacek A, Neiger FX, Spiss CK et al. - Atracurium-induced neuromuscular block is not affected by chronic anticonvulsant therapy with carbamazepine. Acta Anaesthesiol Scand, 1997;41:1308-1311.
18. Spacek A, Nickl S, Neiger FX et al. - Augmentation of the rocuronium-induced neuromuscular block by the acutely administered phenytoin. Anesthesiology, 1999;90:1551-1555.
19. Spacek A, Neiger FX, Krenn CG et al. - Rocuronium-induced neuromuscular block is affected by chronic carbamazepine therapy. Anesthesiology, 1999;90:109-112.
20. Kim JU, Lee YK, Lee YM et al. - The effect of phenytoin on rocuronium-induced neuromuscular block in the rat phrenic nerve-hemidiaphragm preparation. J Neurosurg Anesthesiol, 2005;17:149-152.
21. Bulbring E - Observation on the isolated phyrenic nerve-diaphragm preparation of the rat. Br J Pharmacol, 1946;1:38-61.
22. Leeuwin RS, Wolters ECMJ - Effects of corticosteroids on the sciatic nerve-tibialis anterior muscle of rats treated with hemicholinium-3. Neurology, 1977;27:171-177.
23. Ostergaard D, Engbaek J, Viby-Mogensen J - Adverse reactions and interactions of the neuromuscular blocking drugs. Med Toxicol Adverse Drug Exp, 1989;4:351-368.
24. Anderson GD - A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother, 1998;32:554-563.
25. Ornstein E, Matteo RS, Schwartz AE et al. - The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium. Anesthesiology, 1987;67:191-196.
26. Ornstein E, Matteo RS, Weinstein JA et al. - Accelerated recovery from doxacurium-induced neuromuscular blockade in patients receiving chronic anticonvulsant therapy. J Clin Anesth, 1991;3:108-111.
27. Whalley DG, Ebrahim Z - Influence of carbamazepine on the dose-response relationship of vecuronium. Br J Anaesth, 1994;72:125-126.
28. Norman J - Resistance to vecuronium. Anaesthesia, 1993;48:1068-1069.
29. Roth S, Ebrahim ZY - Resistance to pancuronium in patients receiving carbamazepine. Anesthesiology, 1987;66:691-693.
30. Jellish WS, Modica PA, Tempelhoff R - Accelerated recovery from pipecuronium in patients treated with chronic anticonvulsant therapy. J Clin Anesth, 1993;5:105-108.
31. Jellish WS, Thalji Z, Brundidge PK et al. - Recovery from mivacurium-induced neuromuscular blockade is not affected by anticonvulsant therapy. J Neurosurg Anesthesiol, 1996;8:4-8.
32. Brodie MJ, Dichter MA - Antiepileptic drugs. N Engl J Med, 1996;334:168-175.
33. Alderdice MT, Trommer BA - Differential effects of the anticonvulsants phenobarbital, ethosuximide and carbamazepine on neuromuscular transmission. J Pharmacol Exp Ther, 1980;215:92-96.
34. Platt PR, Thackray NM - Phenytoin-induced resistance to vecuronium. Anaesth Intensive Care, 1993;21:185-191.
35. Hartman GS, Fiamengo SA, Riker WF Jr. - Succinylcholine: mechanism of fasciculations and their prevention by d-tubocurarine or diphenylhydantoin. Anesthesiology, 1986;65:405-413.
36. Kohling R - Voltage-gated sodium channels in epilepsy. Epilepsia, 2002;43:1278-1295.
37. Stoelting RK, Hillier SC - Neuromuscular blocking drugs, em: Stoelting RK, Hillier SC - Pharmacology & Physiology in Anesthetic Practice. Philadelphia, Lippincott Williams & Wilkins, 2006; 208-250.
38. Norris FH Jr, Colella J, Mcfarlin D - Effect of diphenylhydantoin on neuromuscular synapse. Neurology, 1964;14:869-876.
39. Gray HS, Slater RM, Pollard BJ - The effect of acutely administered phenytoin on vecuronium-induced neuromuscular blockade. Anaesthesia, 1989;44:379-381.
40. Nguyen A, Ramzan I - Acute in vitro neuromuscular effects of carbamazepine and carbamazepine-10,11-epoxide. Anesth Analg, 1997;84:886-890.
41. Soriano SG, Sullivan LJ, Venkatakrishnan K et al. - Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy. Br J Anaesth, 2001;86:223-229.
42. Ebrahim ZY, Bulkey R, Roth S - Carbamazepine therapy and neuromuscular blockade with atracurium or vecuronium. Anesth Analg, 1988;67:S55.
43. Fisher DM, Canfell PC, Fahey MR et al. - Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination. Anesthesiology, 1986;65:6-12.
44. Loan PB, Connolly FM, Mirakhur RK et al. - Neuromuscular effects of rocuronium in patients receiving beta-adrenoreceptor blocking, calcium entry blocking and anticonvulsant drugs. Br J Anaesth, 1997;78:90-91.
45. Kim CS, Arnold FJ, Itani MS et al. - Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes. Anesthesiology, 1992;77:500-506.
46. Kremer JM, Wilting J, Janssen LH - Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol Ver, 1988;40:1-47.
47. Martyn JA, Abernethy DR, Greenblatt DJ - Plasma protein binding of drugs after severe burn injury. Clin Pharmacol Ther, 1984;35:535-539.
48. Wood M - Plasma binding and limitation of drug access to site of action. Anesthesiology, 1991;75:721-723.
49. Hans P, Brichant JF, Pieron F et al. - Elevated plasma alpha1-acid glycoprotein levels: lack of connection to resistance to vecuronium blockade induced by anticonvulsant therapy. J Neurosurg Anesthesiol, 1997;9:3-7.
50. Pirttiaho HI, Sotaniemi EA, Pelkonen RO et al. - Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants. Eur J Clin Pharmacol, 1982;22:441-445.